Anteris Technologies Global Corp. — Director's Dealing 2007

Dec 17, 2007

Innovative BioMedical Devices bioMD Limited ABN 35 088 221 078

Level 11, 225 St Georges Terrace Perth, Western Australia 6000 PO Box 7209, Cloisters Square Western Australia 6850

Telephone (08) 9262 6777 Facsimile (08) 9322 3433 www.biomd.com.au

==> picture [50 x 33] intentionally omitted <==

ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE

1 of 2 pages

18 December 2007

Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000

Dear Sir/Madam

Re: Appendix 3Y – Change in Director’s Interest Notice (AMENDED)

The Directors of bioMD Ltd wish to advise of changes to the notifiable interest of a director, in accordance with Listing Rule 3.19A.1 and section 205G of the Corporations Act.

Please refer to the ‘Appendix 3Y’ attached for details of changes in holding.

An amendment has been made to the release made earlier today because the purchase of shares were made in the name of the director and not held in a company’s name. The attached Appendix 3Y corrects the split between Mr Bennett’s direct and indirect holdings in bioMD Limited.

Yours faithfully

==> picture [114 x 85] intentionally omitted <==

CAROLINE L BENTLEY Company Secretary

APPENDIX 3Y CHANGE OF DIRECTOR’S INTEREST NOTICE

Name of Entity: bioMD Limited ABN: 35 055 221 078 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director: Michael Bennett

Date of last notice: 18 December 2007

PART 1 – Change of director's relevant interests in securities

Direct or indirect interest: Indirect / Direct Nature of indirect interest: Mr Bennett is a director of a company holding BOD Date of change: 17 December 2007 No. of securities held prior to change: Ordinary shares Direct: 61,250 Indirect: 8,064,688 Class: Listed ordinary shares (BOD) Number acquired: 38,750 shares Number disposed: N/A Value/Consideration: $4,650 No. of securities held after change: Ordinary shares Direct: 100,000 Indirect: 8,064,688 Nature of the change: On market purchase

PART 2 – Change of director’s interests in contracts

Details of contract: None Applicable

Nature of interest: Name of registered holder: (if issued securities) No. and class of securities to which interest relates: Interest acquired: Interest disposed: Value/Consideration: Interest after change: